OptimizeRx Corp. announced the appointment of Steve Silvestro as the company's new Chief Executive Officer, effective March 10, 2025. Mr. Silvestro had previously served as interim CEO since January 2025.
The Board of Directors conducted a rigorous search and selection process, unanimously deciding to appoint Mr. Silvestro. He brings over 20 years of experience in building and managing health technology and services companies.
Mr. Silvestro's prior roles at OptimizeRx include Chief Commercial Officer and President, demonstrating his deep understanding of the company's operations and strategic objectives. His appointment aims to drive the next phase of profitable revenue growth and shareholder value creation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.